Japanese Pharmaceuticals & Biotech High Growth Potential Companies

Kidswell Bio

Market Cap: JP¥12.2b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

GNI Group

Market Cap: JP¥165.7b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥24.2b

Engages in the regenerative medicine business in Japan.

Sawai Group Holdings

Market Cap: JP¥211.6b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Daiichi Sankyo Company

Market Cap: JP¥6.3t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

RaQualia Pharma

Market Cap: JP¥13.4b

Engages in the research and development of pharmaceutical compounds worldwide.

Takara Bio

Market Cap: JP¥96.1b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Nxera Pharma

Market Cap: JP¥81.2b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Takeda Pharmaceutical

Market Cap: JP¥6.9t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Eisai

Market Cap: JP¥1.2t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Chugai Pharmaceutical

Market Cap: JP¥12.4t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥59.7b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

JCR Pharmaceuticals

Market Cap: JP¥62.5b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

PeptiDream

Market Cap: JP¥212.5b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Daito PharmaceuticalLtd

Market Cap: JP¥29.9b

Manufactures and sells pharmaceutical products worldwide.

Fuji Pharma

Market Cap: JP¥33.1b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.